Skip to main content

Experts talk how to navigate distressing news stories and finding coping mechanisms

BATON ROUGE, La. (AP) — As people awoke to headlines over the weekend about deadly U.S.-Israeli strikes on Iran and potential of widening conflict, alerts, social media and conversations at the dining room table were consumed by the news.

While medical experts say it is normal for people to experience stress and anxiety — or feeling that the world descended into chaos overnight — it is important to find coping mechanisms and ways to responsibly take in the news in order to protect one’s mental health.

“Fear, sadness, confusion… these are very normal reactions to very extreme circumstances,” Michael S. Ziffra, a Northwestern Feinberg School of Medicine professor and psychiatrist, told The Associated Press. “People shouldn’t feel guilty, or they shouldn’t feel like it’s wrong to feel anxiety. It’s a very normal human response. The key is to know how to manage it.”

Normal feelings

Since 2020 — a year marked by the deadly COVID-19 pandemic, social and political unrest and weather-related disasters — Ziffra said he has “absolutely, without question” seen an uptick in patients bringing up increased anxiety provoked by current news.

Some patients vent, some talk about obsessively scrolling on social media and others discuss feeling helpless and frustrated.

But, psychiatrists say those feelings are absolutely normal and to be expected. In fact, sometimes they can result in something positive — from getting involved in advocacy, joining a social or political organization or just contacting lawmakers.

Other’s may seek to learn more about what is going on. But like with most things in life, moderation is important.

“The problem is, for a lot of people, they just kind of wallow in it. They ruminate and obsess and just sort of stew in it,” Ziffra said.

Consuming distressing news

In today’s world, people are just a click away from learning about practically anything they want — sometimes even less, with a predetermined algorithm on social media pushing posts or alerts on their phone interrupting their day. People have access to 24/7 news cycles and phone cameras can capture, and disseminate, videos and images of disasters within seconds.

For years, Dana Rose Garfin, a psychologist and professor at University of California, Los Angeles, has been studying “cascading collective traumas” and researched how the media’s continuous coverage of COVID increased anxiety. Garfin said the reality is that people don’t consume the news how they used to. Instead of reading a newspaper or flipping on the evening news once a day, people are “much more exposed” to current events.

And as people learn about disasters or breaking news, they become distressed.

“In terms of any kind of crisis, people turn to the media for information. And that’s a very logical, rational and helpful reaction,” Garfin said.

“But, what we’ve seen in our research is there’s this sort of reciprocal effect. An event happens, people learn about it, they turn to the media to learn more about it, and they’re really distressed,” Garfin said, adding that what occurs next is a cycle that people have a hard time removing themselves from. “It sort of activates these processes where then they’re both more distressed and want to know more about this event because they’re distressed.”

Responsibly consuming media

While experts said they understand people’s need to continue to seek out news, there is a way to do it responsibly without becoming overwhelmed and emotionally exhausted. Their top suggestion was to eliminate or cut down on social media and obsessive “doomscrolling.”

“I don’t immerse myself in social media, and that’s a very conscious decision on my part to protect my own mental, and physical, health,” said Roxane Cohen Silver, a psychologist at the University of California, Irvine, and who co-authored the study with Garfin. She specifically raised concerns about graphic images and video that quickly circulate on social media that can cause distress and long-term anxiety when seen repeatedly.

“I think that one can stay informed without immersing oneself in graphic images,” she said.

Garfin suggested finding more “enjoyable” ways to consume news, such as an informative news article, listening to a podcast or watching a news segment. “That’s different than this kind of letting the algorithm suck you in for eternity in a mindless fashion.”

Experts also urged people to set timers, when scrolling on their phone. Both iPhones and Android devices have controls to help regulate screen time.

Ziffra suggested choosing neutral news sources. “Try to avoid things where it’s very partisan and where there’s going to be a lot of inflammatory content, because that’s going to likely exacerbate your anxiety and make you feel anxious, angry, scared.”

Identifying coping mechanisms

Even if a worrisome news event is happening thousands of miles away, and even if it doesn’t directly impact a person reading about it, it can still cause intense stress and anxiety. For that reason, medical experts urge people to identify other ways to cope.

“People have a lot of inherent knowledge of what helps them… and things that they find comfort in, which is different for everybody,” Garfin said.

From breathing exercises, going for a walk, leaning into hobbies, getting together with friends, talking to a therapist, creative pursuits and self care, psychiatrists say it is important to redirect your attention in other ways.

“Things that are going to get your mind off of all of the obsessing and worrying and really putting your thoughts on something more positive,” Ziffra said.

When you have advanced prostate cancer: What living with the disease looks like

(CNN) — “How long do I have to live ?”When I tell a patient he has prostate cancer, this is usually what he asks me first.With early-stage or low-grade prostate cancer, I can offer strong reassurance: Your life expectancy is good — expect a five-year relative survival rate of greater than 99% with treatment. Simply put, most men will not die from low-grade prostate cancer.However, once the cancer has spread outside the prostate to the bones and other organs the answer becomes more difficult. Treatment has changed dramatically over the past decade for advanced prostate cancer. New drugs, better imaging and the earlier use of combined therapies are helping men live longer.In a video released July 15, former President Joe Biden gave an update on his prostate cancer, saying he was receiving treatments that have been going well. In May 2025, Biden officially announced that he had an aggressive form of prostate cancer that had spread to his bones. Since then, based on official updates, he has continued hormone therapy, completed a course of radiation and maintained a public presence.His diagnosis brought renewed attention to prostate cancer screening and treatment. Now, more than a year later, his cancer journey offers an opportunity to examine what has changed in the treatment of advanced prostate cancer — and the hope these offer men living with the disease.I recently saw a patient who was diagnosed three years ago with cancer that had already spread to multiple areas in his bones. Since then, he has taken cruises, traveled with his family and spent weekends babysitting his grandchildren.He gets tired and cannot garden the way he once did. But he is still alive and considers every day a blessing. His experience, and what we see with Biden, shows what living with metastatic prostate cancer can look like today.Understanding survival ratesIf they haven’t asked their doctor already, many patients go online and find five-year survival rates, but every number they may find online comes with a huge asterisk.The American Cancer Society reports five-year relative survival of greater than 99% when prostate cancer is found in or near the prostate. The figure drops to 38% when it has reached distant parts of the body.But that number is based on large groups of men treated years ago. It does not fully reflect the impact of newer treatments — or account for an individual man’s age, overall health and response to therapy.Survival statistics describe groups of patients but do not predict what will happen to one person. That is why the 38% figure cannot tell us how long Biden — or any individual patient — will live. These patients’ outlook depends on details of their cancer and how they are responding to treatments.It’s treated more aggressively nowA man diagnosed with metastatic prostate cancer a decade ago and a man diagnosed today would not receive the same treatment. The thinking now is to use our best treatments early instead of holding back.For years, doctors began with hormone therapy — usually injections that lower testosterone — and saved other treatments until the cancer stopped responding.Today, those injections are often combined from the start with a newer hormone-blocking drug and/or chemotherapy. These combinations have helped men live longer and are one of the biggest shifts of the past decade.What Biden’s diagnosis told usThere are three details about Biden’s cancer that help doctors like me understand how aggressive it is and how to manage it effectively. Official statements highlighted that his cancer had a Gleason score of 9. The cancer had spread to his bones, and it was labeled as hormone-sensitive.The Gleason score is assigned after a pathologist examines biopsy samples. Scores typically range from 6 to 10, with higher numbers indicating more aggressive cancer. A score of 9 falls into the most aggressive category. However, the score alone cannot tell us whether the cancer has spread outside the prostate.When prostate cancer spreads, the most common destination is the bones — particularly the spine, pelvis and ribs. It can also reach organs such as the lungs or liver. Once it has reached distant parts of the body, it is generally not curable, but treatment can put a brake on it for years.Prostate cancer can also be hormone-sensitive or hormone-resistant. Because it typically relies on testosterone to grow, lowering the hormone or blocking its effects can help control the cancer. Hormone-sensitive means it still responds to these treatments.Over time, most advanced or metastatic prostate cancers find ways to grow despite low testosterone levels, which mean they are now hormone-resistant. Lowering testosterone alone is no longer enough to control the cancer, so doctors have to turn to additional therapies.Knowing if the cancer has spreadThe most sensitive imaging test available today is a PSMA PET scan. It uses a radioactive tracer that seeks out a protein found on the surface of prostate cancer cells. Areas containing cancer may appear as bright spots, helping identify where the cancer has spread. The American Urological Association supports using this imaging test to determine whether high-risk prostate cancer has spread and to help establish its stage.A traditional bone scan, used for decades, highlights areas where bone is reacting to injury or disease. It remains an alternative imaging option, but PSMA PET is increasingly replacing its use.What areas light up and where matter when deciding on treatments. A single spot in the spine and cancer that has spread to the liver are both called stage 4, but they are not the same disease and may not be treated the same way.Doctors also consider how much cancer has spread. We label it as “low-volume” disease when the cancer has reached a limited number of areas. High volume is when the spread is more widespread or has reached other organs such as the liver or lungs.Both require treatment that works throughout the body. Treatment for metastatic disease generally includes therapy that works throughout the body. For men with low-volume disease, adding radiation to the prostate may also help them live longer.Biden has completed a course of radiation, but his team has not disclosed what area was treated or enough detail to determine whether his cancer would be considered low- or high-volume.Treatment has become more preciseBeyond starting more treatments earlier, doctors can increasingly tailor therapy to the biology of an individual man’s cancer. We can now test both the tumor and a patient’s own DNA for mutations that help guide treatment.Roughly 1 in 10 men with metastatic prostate cancer carries an inherited mutation affecting the body’s ability to repair DNA. The best known are BRCA1 and BRCA2, the same genes linked to some breast and ovarian cancers.Certain mutations found in the tumor or inherited DNA may make targeted drugs called PARP inhibitors an option. If a mutation is inherited, it also gives family members information they can act on through genetic counseling, testing and earlier screening.Another advance is radioligand therapy. If a scan shows that cancer cells carry a protein called PSMA, doctors can attach radiation to a molecule that seeks out that protein. Delivered through an IV, it targets cancer cells throughout the body. This approach was expanded last year to more men whose cancer had become hormone resistant.Living longer can come with costsEvery treatment can cause side effects. With hormone therapy, one of the first is often hot flashes, similar to what women experience during menopause. These are not dangerous, but they can affect a man’s quality of life.Fatigue is also common. Testosterone helps maintain muscle, so lowering it can reduce strength and energy. Regular walking and resistance training can help preserve muscle and reduce fatigue.The side effect almost no one talks about is loss of sex drive or low libido. At diagnosis, most men are thinking about staying alive, not their libido. But months later, it often matters. It is worth discussing with your care team and your partner rather than assuming it is simply the price of treatment.The side effect I worry about most is weaker bones. Low testosterone reduces bone density, while cancer deposits can weaken the bone’s structure. Follow-up care should include exercise, a bone-density scan, and ensuring adequate levels of calcium and vitamin D. For men with hormone-resistant cancer that has spread to bone, bone-protecting drugs can reduce the risk of fractures and other complications.New or worsening back pain, especially with leg weakness, numbness or trouble controlling the bladder or bowels? These could mean the cancer is pressing on the spinal cord. It is a true medical emergency that requires immediate attention.Cancer care requires a team approachIdeally, several doctors work together to coordinate a patient’s care. The urologist is often the starting point. A medical oncologist manages treatments that work throughout the body, while a radiation oncologist targets specific areas, whether that is the prostate itself or a painful bone lesion. The primary care doctor helps protect the patient’s heart and bones and looks after the person’s overall health.A man’s age, other medical conditions, ability to tolerate side effects and goals for treatment all shape treatment plans. Two men with nearly identical test results may be offered — or choose — different paths based on their health and priorities.Good communication among doctors is essential, but gaps can happen. Being your own advocate means knowing who is on your care team, asking questions and understanding your options.I also recommend bringing someone you trust to important visits for support and to take notes and help you remember what was discussed.More treatments, better testing offer hopeFor men worried about prostate cancer, talk with your health care provider about the benefits and risks of PSA testing. Black men and those with a strong family history should begin that conversation in their 40s. New urinary symptoms are often not cancer, but they still deserve attention, as does blood in the urine or semen, unexplained weight loss and/or persistent back or bone pain.For men living with advanced prostate cancer, there is reason for hope. There are more treatments and better testing than there were a decade ago, and good care pays attention to how a man feels, not just to what his scans show.The-CNN-Wire™ & © 2026 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved.
Read Next Story